| Authors: |
Popescu AS; Department of Biochemistry, University of Cambridge, Cambridge, UK., Butler CA; Department of Biochemistry, University of Cambridge, Cambridge, UK.; Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Allendorf DH; Department of Biochemistry, University of Cambridge, Cambridge, UK., Piers TM; Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK., Mallach A; Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK., Roewe J; Neuroscience Discovery, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany., Reinhardt P; Neuroscience Discovery, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany., Cinti A; Cell Biology, Axxam SpA, Milan, Italy., Redaelli L; Cell Biology, Axxam SpA, Milan, Italy., Boudesco C; Rare and Neuro Diseases, Sanofi R&D, Chilly-Mazarin, France., Pradier L; Rare and Neuro Diseases, Sanofi R&D, Chilly-Mazarin, France., Pocock JM; Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK., Thornton P; Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Brown GC; Department of Biochemistry, University of Cambridge, Cambridge, UK. |
